CTSL and type 1 diabetes mellitus: Here the role of cathepsin L in cyclophosphamide (CY)-treated nonobese diabetic (NOD) mice, a model for spontaneous T1D [11], [12] using a cathepsin L-specific inhibitor was investigated.